Relevance of carnosic acid to the treatment of several health disorders: Molecular targets and mechanisms

Biomedicine and Pharmacotherapy

Volumn 84, Issue , 2016, Pages 569-582

  Bahri, Sana ^a,b   Jameleddine, Saloua ^a   Shlyonsky, Vadim ^b  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Anti inflammatory; Antioxidant; Antitumor; Carnosic acid

Indexed keywords

CARNOSIC ACID; NATURAL PRODUCT; ROSMARINIC ACID; ABIETANE DERIVATIVE; ANTINEOPLASTIC AGENT; ANTIOBESITY AGENT; DERMATOLOGICAL AGENT; GASTROINTESTINAL AGENT; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; BRAIN CANCER; CELL FUNCTION; COLORECTAL CANCER; DISEASE MANAGEMENT; DISEASES; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; EXPERIMENTAL ATHEROSCLEROSIS; EXPERIMENTAL BRAIN INJURY; EXPERIMENTAL DISEASE; EXPERIMENTAL LIVER INJURY; EXPERIMENTAL PARKINSONISM; HEART INJURY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; NEUROPROTECTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RETINA DEGENERATION; REVIEW; SIGNAL TRANSDUCTION; SKIN DEFECT; STOMACH LESION; ANIMAL; BIOAVAILABILITY; DISEASE MODEL;

ANIMALS; ANTI-OBESITY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AVAILABILITY; DERMATOLOGIC AGENTS; DISEASE MODELS, ANIMAL; DITERPENES, ABIETANE; GASTROINTESTINAL AGENTS; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 84988976356     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.09.067     Document Type: Review

References (116)

1. [1] Linde, H., Ein neues diterpen aus salvia officinalis L. und eine notiz zur konstitution von pikrosalvin. Helv. Chim. Acta 47 (1964), 1234–1239.
2. [2] Wenkert, E., Fuchs, A., Mc Chesney, J.D., Chemical artifacts from the family Labiatae. J. Org. Chem. 30 (1965), 2931–2934.
3. [3] Hill, R.A., Connoly, J.D., Triterpenoids. Nat. Prod. Rep. 30 (2013), 1028–1065.
4. [4] Munne-Bosch, S., Alegre, L., Changes in carotenoids, tocopherols and diterpenes during drought and recovery, and the biological significance of chlorophyll loss in Rosmarinus officinalis plants. Planta 210 (2000), 925–931.
5. [5] Steiner, M., Priel, I., Giat, J., Levy, J., Sharoni, Y., Danilenko, M., Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid. Nutr. Cancer 41 (2001), 135–144.
6. [6] Doolaege, E.H., Raes, K., De Vos, F., Verhé, R., De Smet, S., Absorption, distribution and elimination of carnosic acid, a natural antioxidant from Rosmarinus officinalis, in rats. Plant Foods Hum. Nutr. 66 (2011), 196–202.
7. [7] Romo Vaquero, M., García Villalba, R., Larrosa, M., Yáñez-Gascón, M.J., Fromentin, E., Flanagan, J., Roller, M., Tomás-Barberán, F.A., Espín, J.C., García-Conesa, M.T., Bioavailability of the major bioactive diterpenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats. Mol. Nutr. Food Res. 57 (2013), 1834–1846.
8. [8] Wang, Q.L., Li, H., Li, X.X., Cui, C.Y., Wang, R., Yu, N.X., Chen, L.X., Acute and 30-day oral toxicity studies of administered carnosic acid. Food Chem. Toxicol. 50 (2012), 4348–4355.
9. [9] Barni, M.V., Carlini, M.J., Cafferata, E.G., Puricelli, L., Moreno, S., Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells. Oncol. Rep. 27 (2012), 1041–1048.
10. [10] Kim, D.H., Park, K.W., Chae, I.G., Kundu, J., Kim, E.H., Kundu, J.K., Chun, K.S., Carnosic acid inhibits STAT3 signaling and induces apoptosis through generation of ROS in human colon cancer HCT116 cells. Mol. Carcinog. 55 (2015), 1096–1110.
11. [11] Kim, Y.J., Kim, J.S., Seo, Y.R., Park, J.H., Choi, M.S., Sung, M.K., Carnosic acid suppresses colon tumor formation in association with antiadipogenic activity. Mol. Nutr. Food Res. 58 (2014), 2274–2285.
12. [12] Borrás-Linares, I., Pérez-Sánchez A, A., Lozano-Sánchez, J., Barrajón-Catalán, E., Arráez-Román, D., Cifuentes, A., Micol, V., Carretero, A.S., A bioguided identification of the active compounds that contribute to the antiproliferative/cytotoxic effects of rosemary extract on colon cancer cells. Food Chem. Toxicol. 80 (2015), 215–222.
13. [13] Gao, Q., Liu, H., Yao, Y., Geng, L., Zhang, X., Jiang, L., Shi, B., Yang, F., Carnosic acid induces autophagic cell death through inhibition of the Akt/mTOR pathway in human hepatoma cells. J. Appl. Toxicol. 35 (2015), 485–492.
14. [14] Xiang, Q., Ma, Y., Dong, J., Shen, R., Carnosic acid induces apoptosis associated with mitochondrial dysfunction and Akt inactivation in HepG2 cells. Int. J. Food Sci. Nutr. 66 (2015), 76–84.
15. [15] Arico, S., Petiot, A., Bauvy, C., Dubbelhuis, P.F., Meijer, A.J., Codogno, P., Ogier-Denis, E., The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 2765 (2001), 35243–35246.
16. [16] Oral O, O., Y. Akkoc, Y., O. Bayraktar, O., D. Gozuacik, D., Physiological and pathological significance of the molecular cross-talk between autophagy and apoptosis. Histol. Histopathol., 18, 2015, 11714.
17. [17] Thoburn, A., Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 13 (2008), 1–9.
18. [18] Thorburn, J., Moore, F., Rao, A., Barclay, W.W., Thomas, L.R., Grant, K.W., Cramer, C.D., Thorburn, A., Selective inactivation of a FADD-dependent apoptosis and autophagy pathway in immortal epithelial cells. Mol. Biol. Cell 16 (2005), 1189–1199.
19. [19] Pyo, J.O., Jang, M.H., Kwon, Y.K., Lee, H.J., Jun, J.I., Woo, H.N., Cho, D.H., Choi, B., Lee, H., Kim, J.H., Mizushima, N., Oshumi, Y., Jung, Y.K., Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J. Biol. Chem. 280 (2005), 20722–20729.
20. [20] Martin, A.P., Mitchell, C., Rahmani, M., Nephew, K.P., Grant, S., Dent, P., Inhibition of MCL-1 enhances lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy. Cancer Biol. Ther. 8 (2009), 2084–2096.
21. [21] Yousefi, S., Perozzo, R., Schmid, I., Ziemiecki, A., Schaffner, T., Scapozza, L., Brunner, T., Simon, H.U., Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell Biol. 8 (2006), 1124–1132.
22. [22] Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N., Packer, M., Schneider, M.D., Levine, B., Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell 122 (2005), 927–939.
23. [23] Costa, S., Utan, A., Speroni, E., Cervellati, R., Piva, G., Prandini, A., Guerra, M.C., Carnosic acid from rosemary extracts: a potential chemoprotective agent against aflatoxin B1. An in vitro study. J. Appl. Toxicol. 27 (2007), 152–159.
24. [24] Min, K.J., Jung, K.J., Kwon, T.K., Carnosic acid induces apoptosis through reactive oxygen species-mediated endoplasmic reticulum stress induction in human renal carcinoma caki cells. J. Cancer Prev. 19 (2014), 170–178.
25. [25] Jung, K.J., Min, K.J., Bae, J.H., Kwon, T.K., Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells. Oncotarget 6 (2015), 1556–1568.
26. [26] Kosaka, K., Mimura, J., Itoh, K., Satoh, T., Shimojo, Y., Kitajima, C., Maruyama, A., Yamamoto, M., Shirasawa, T., Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells. J. Biochem. 147 (2010), 73–81.
27. [27] de Oliveira, M.R., Ferreira, G.C., Schuck, P.F., Dal Bosco, S.M., Role for the PI3 K/Akt/Nrf2 signaling pathway in the protective effects of carnosic acid against methylglyoxal-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Chem. Biol. Interact. 242 (2015), 396–406.
28. [28] Tsai, C.W., Lin, C.Y., Lin, H.H., Chen, J.H., Carnosic acid, a rosemary phenolic compound, induces apoptosis through reactive oxygen species-mediated p38 activation in human neuroblastoma IMR-32 cells. Neurochem. Res. 36 (2011), 2442–2451.
29. [29] Ren, L.H., Chen, J.J., An, H.P., Enhancement of differentiation induction of HL-60 cells by 1,25-dihydroxyvitamin D3 in combination with carnosic acid. Zhongguo Dang Dai Er Ke Za Zhi. 10 (2008), 55–59.
30. [30] Danilenko, M., Wang, Q., Wang, X., Levy, J., Sharoni, Y., Studzinski, G.P., Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1α, 25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium. Cancer Res. 63 (2003), 1325–1332.
31. [31] Shabtay, A., Sharabani, H., Barvish, Z., Kafka, M., Amichay, D., Levy, J., Sharoni, Y., Uskokovic, M.R., Studzinski, G.P., Danilenko, M., Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia. Oncology 75 (2008), 203–214.
32. [32] Pesakhov, S., Khanin, M., Studzinski, G.P., Danilenko, M., Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells. Nutr. Cancer 62 (2010), 811–824.
33. [33] Pesakhov, S., Nachliely, M., Barvish, Z., Aqaqe, N., Schwartzman, B., Voronov, E., Sharoni, Y., Studzinski, G.P., Fishman, D., Danilenko, M., Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid. Oncotarget, 2016, 10.18632/oncotarget.7240.
34. [34] Wang, R., Cong, W.H., Guo, G., Li, X.X., Chen, X.L., Yu, X.N., Li, H., Synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis is associated with modulation of PTEN/Akt signaling pathway. Chin. J. Integr. Med. 18 (2012), 934–941.
35. [35] Yu, X.N., Chen, X.L., Li, X.X., Li, H.Q., Jin, W.R., Reversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by carnosic acid. Chin. J. Physiol. 51 (2008), 348–356.
36. [36] Wang, L.Q., Wang, R., Li, X.X., Yu, X.N., Chen, X.L., Li, H., The anti-leukemic effect of carnosic acid combined with adriamycin in a K562/A02/SCID leukemia mouse model. Int. J. Clin. Exp. Med. 8 (2015), 11708–11717.
37. [37] López-Jiménez, A., García-Caballero, M., Medina, M.Á., Quesada, A.R., Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary. Eur. J. Nutr. 52 (2013), 85–95.
38. [38] Kayashima, T., Matsubara, K., Antiangiogenic effect of carnosic acid and carnosol, neuroprotective compounds in rosemary leaves. Biosci. Biotechnol. Biochem. 76 (2012), 115–119.
39. [39] Park, S.Y., Song, H., Sung, M.K., Kang, Y.H., Lee, K.W., Park, J.H., Carnosic acid inhibits the epithelial-mesenchymal transition in B16F10 melanoma cells: a possible mechanism for the inhibition of cell migration. Int. J. Mol. Sci. 15 (2014), 12698–12713.
40. [40] Kar, S., Palit, S., Ball, W.B., Das, P.K., Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Apoptosis 17 (2012), 735–747.
41. [41] Yesil-Celiktas, O., Sevimli, C., Bedir, E., Vardar-Sukan, F., Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant Foods Hum. Nutr. 65 (2010), 158–163.
42. [42] Einbond, L.S., Wu, H.A., Kashiwazaki, R., He, K., Roller, M., Su, T., Wang, X., Goldsberry, S., Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin. Fitoterapia 83 (2012), 1160–1168.
43. [43] Xiang, Q., Liu, Z., Wang, Y., Xiao, H., Wu, W., Xiao, C., Liu, X., Carnosic acid attenuates lipopolysaccharide-induced liver injury in rats via fortifying cellular antioxidant defense system. Food Chem. Toxicol. 53 (2013), 1–9.
44. [44] Tian, X., Hu, Y., Li, M., Xia, K., Yin, J., Chen, J., Liu, Z., Carnosic acid attenuates acute ethanol-induced liver injury via a SIRT1/p66Shc-mediated mitochondrial pathway. Can. J. Physiol. Pharmacol. 22 (2015), 1–10.
45. [45] Guo, Q., Shen, Z., Yu, H., Lu, G., Yu, Y., Liu, X., Zheng, P., Carnosic acid protects against acetaminophen-induced hepatotoxicity by potentiating Nrf2-mediated antioxidantcapacity in mice. Korean J. Physiol. Pharmacol. 20 (2016), 15–23.
46. [46] Shan, W., Gao, L., Zeng, W., Hu, Y., Wang, G., Li, M., Zhou, J., Ma, X., Tian, X., Yao, J., Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease. Cell Death Dis., 6, 2015, e1833.
47. [47] Gao, L., Shan, W., Zeng, W., Hu, Y., Wang, G., Tian, X., Zhang, N., Shi, X., Zhao, Y., Ding, C., Zhang, F., Liu, K., Yao, J., Carnosic acid alleviates chronic alcoholic liver injury by regulating the SIRT1/ChREBP and SIRT1/p66shc pathways in rats. Mol. Nutr. Food Res., 2016, 10.1002/mnfr.201500878.
48. [48] Hu, Y., Zhang, N., Fan, Q., Lin, M., Zhang, C., Fan, G., Zhai, X., Zhang, F., Chen, Z., Yao, J., Protective efficacy of carnosic acid against hydrogen peroxide induced oxidative injury in HepG2 cells through the SIRT1 pathway. Can. J. Physiol. Pharmacol. 93 (2015), 625–631.
49. [49] Wang, T., Takikawa, Y., Carnosic acid protects normal mouse hepatocytes against H2 O2 -induced cytotoxicity via sirtuin 1-mediated signaling. Hepatol. Res. 46 (2016), 239–246.
50. [50] Sahu, B.D., Putcha, U.K., Kuncha, M., Rachamalla, S.S., Sistla, R., Carnosic acid promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress and apoptosis in mice. Mol. Cell Biochem. 394 (2014), 163–176.
51. [51] Kocak, C., Kocak, F.E., Akcilar, R., Isiklar, O.O., Kocak, H., Bayat, Z., Simsek, H., Taser, F., Altuntas;1, I., Molecular and biochemical evidence on the protective effects of embelin and carnosic acid in isoproterenol-induced acute myocardial injury in rats. Life Sci. 147 (2016), 15–23.
52. [52] Yu, Y.M., Lin, H.C., Chang, W.C., Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9. Br. J. Nutr. 100 (2008), 731–738.
53. [53] Yu, Y.M., Lin, C.H., Chan, H.C., Tsai, H.D., Carnosic acid reduces cytokine-induced adhesion molecules expression and monocyte adhesion to endothelial cells. Eur. J. Nutr. 48 (2009), 101–106.
54. [54] Meng, P., Yoshida, H., Matsumiya, T., Imaizumi, T., Tanji, K., Xing, F., Hayakari, R., Dempoya, J., Tatsuta, T., Aizawa-Yashiro, T., Mimura, J., Kosaka, K., Itoh, K., Satoh, K., Carnosic acid suppresses the production of amyloid-β 1–42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells. Neurosci. Res. 75 (2013), 94–102.
55. [55] Azad, N., Rasoolijazi, H., Joghataie, M.T., Soleimani, S., Neuroprotective effects of carnosic acid in an experimental model of Alzheimer's disease in rats. Cell J. Spring. 13 (2011), 39–44.
56. [56] Rasoolijazi, H., Azad, N., Joghataei, M.T., Kerdari, M., Nikbakht, F., Soleimani, M., The protective role of carnosic acid against beta-amyloid toxicity in rats. Sci. World J., 2013, 917082, 10.1155/2013/917082.
57. [57] Meng, P., Yoshida, H., Matsumiya, T., Imaizumi, T., Tanji, K., Xing, F., Hayakari, R., Dempoya, J., Tatsuta, T., Aizawa-Yashiro, T., Mimura, J., Kosaka, K., Itoh, K., Satoh, K., Carnosic acid suppresses the production of amyloid-β 1–42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells. Neurosci. Res. 75 (2013), 94–102.
58. [58] Meng, P., Yoshida, H., Tanji, K., Matsumiya, T., Xing, F., Hayakari, R., Wang, L., Tsuruga, K., Tanaka, H., Mimura, J., Kosaka, K., Itoh, K., Takahashi, I., Kawaguchi, S., Imaizumi, T., Carnosic acid attenuates apoptosis induced by amyloid-β 1–42 or 1–43 in SH-SY5Y human neuroblastoma cells. Neurosci. Res. 94 (2015), 1–9.
59. [59] de Oliveira, M.R., Ferreira, G.C., Schuck, P.F., Dal Bosco, S.M., Role for the PI3 K/Akt/Nrf2 signaling pathway in the protective effects of carnosic acid against methylglyoxal-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Chem. Biol. Interact. 242 (2015), 396–406.
60. [60] Kanthasamy, A.G., Kitazawa, M., Yang, Y., Anantharam, V., Kanthasamy, A., Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): implications for neurodegeneration in Parkinson's disease. Mol. Brain, 1, 2008, 12.
61. [61] Gee, L.E., Chen, N., Ramirez-Zamora, A., Shin, D.S., Pilitsis, J.G., The effects of subthalamic deep brain stimulation on mechanical and thermal thresholds in 6OHDA-lesioned rats. Eur. J. Neurosci. 42 (2015), 2061–2069.
62. [62] Zhang, D., Lee, B., Nutter, A., Song, P., Dolatabadi, N., Parker, J., Sanz-Blasco, S., Newmeyer, T., Ambasudhan, R., McKercher, S.R., Masliah, E., Lipton, S.A., Protection from cyanide-induced brain injury by the Nrf2 transcriptional activator carnosic acid. J. Neurochem. 133 (2015), 898–908.
63. [63] Filograna, R., Godena, V.K., Sanchez-Martinez, A., Ferrari, E., Casella, L., Beltramini, M., Bubacco, L., Whitworth, A.J., Bisaglia, M., SOD-mimetic M40403 is protective in cell and fly models of paraquat toxicity: implications for Parkinson disease. J. Biol. Chem. 291 (2016), 9257–9267.
64. [64] Park, J.A., Kim, S., Lee, S.Y., Kim, C.S., Kim do, K., Kim, S.J., Chun, H.S., Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death. Neuroreport 19 (2008), 1301–1304.
65. [65] Chen, J.H., Ou, H.P., Lin, C.Y., Lin, F.J., Wu, C.R., Chang, S.W., Tsai, C.W., Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis. Chem. Res. Toxicol. 25 (2012), 1893–1901.
66. [66] Lin, C.Y., Chen, J.H., Fu, R.H., Tsai, C.W., Induction of Pi form of glutathione S-transferase by carnosic acid is mediated through PI3 K/Akt/NF-κB pathway and protects against neurotoxicity. Chem. Res. Toxicol. 27 (2015), 1958–1966.
67. [67] Lin, C.Y., Tsai, C.W., Tsai, C.W., Carnosic acid protects SH-SY5Y cells against 6-hydroxydopamine-induced cell death through upregulation of parkin pathway. Neuropharmacology 3908 (2016), 30157–30165.
68. [68] Zhang, D., Lee, B., Nutter, A., Song, P., Dolatabadi, N., Parker, J., Sanz-Blasco, S., Newmeyer, T., Ambasudhan, R., McKercher, S.R., Masliah, E., Lipton, S.A., Protection from cyanide-induced brain injury by the Nrf2 transcriptional activator carnosic acid. J. Neurochem. 133 (2015), 898–908.
69. [69] de Oliveira, M.R., Ferreira, G.C., Schuck, P.F., Protective effect of carnosic acid against paraquat-induced redox impairment and mitochondrial dysfunction in SH-SY5Y cells: role for PI3 K/Akt/Nrf2 pathway. Toxicol. In Vitro 32 (2016), 41–54.
70. [70] Wu, C.R., Tsai, C.W., Chang, S.W., Lin, C.Y., Huang, L.C., Tsai, C.W., Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. Chem. Biol. Interact. 225 (2015), 40–46.
71. [71] Rezaie, T., McKercher, S.R., Kosaka, K., Seki, M., Wheeler, L., Viswanath, V., Chun, T., Joshi, R., Valencia, M., Sasaki, S., Tozawa, T., Satoh, T., Lipton, S.A., Protective effect of carnosic acid, a pro-electrophilic compound, in models of oxidative stress and light-induced retinal degeneration. Invest. Ophthalmol. Vis. Sci. 53 (2012), 7847–7854.
72. [72] Kang, K., Tarchick, M.J., Yu, X., Beight, C., Bu, P., Yu, M., Carnosic acid slows photoreceptor degeneration in the Pde6b(rd10) mouse model of retinitis pigmentosa. Sci. Rep., 6, 2016, 22632.
73. [73] Kansanen, E., Kuosmanen, S.M., Leinonen, H., Levonen, A.L., The Keap1Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 1 (2013), 45–49.
74. [74] Satoh, T., Kosaka, K., Itoh, K., Kobayashi, A., Yamamoto, M., Shimojo, Y., Kitajima, C., Cui, J., Kamins, J., Okamoto, S., Izumi, M., Shirasawa, T., Lipton, S.A., Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J. Neurochem. 104 (2008), 1116–1131.
75. [75] Satoh, T., Izumi, M., Inukai, Y., Tsutsumi, Y., Nakayama, N., Kosaka, K., Shimojo, Y., Kitajima, C., Itoh, K., Yokoi, T., Shirasawa, T., Carnosic acid protects neuronal HT22 cells through activation of the antioxidant-responsive element in free carboxylic acid- and catechol hydroxyl moieties-dependent manners. Neurosci. Lett. 434 (2008), 260–265.
76. [76] Tamaki, Y., Tabuchi, T., Takahashi, T., Kosaka, K., Satoh, T., Activated glutathione metabolism participates in protective effects of carnosic acid against oxidative stress in neuronal HT22 cells. Planta Med. 76 (2010), 683–688.
77. [77] Miller, D.M., Singh, I.N., Wang, J.A., Hall, E.D., Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radic. Biol. Med. 57 (2013), 1–9.
78. [78] Miller, D.M., Singh, I.N., Wang, J.A., Hall, E.D., Nrf2-ARE activator carnosic acid decreases mitochondrial dysfunction, oxidative damage and neuronal cytoskeletal degradation following traumatic brain injury in mice. Exp. Neurol. 264 (2014), 103–110.
79. [79] Kosaka, K., Mimura, J., Itoh, K., Satoh, T., Shimojo, Y., Kitajima, C., Maruyama, 1A., Yamamoto, M., Shirasawa, T., Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12 h cells. J. Biochem. 147 (2010), 73–81.
80. [80] Mimura, J., Kosaka, K., Maruyama, A., Satoh, T., Harada, N., Yoshida, H., Satoh, K., Yamamoto, M., Itoh, K., Nrf2 regulates NGF mRNA induction by carnosic acid in T98G glioblastoma cells and normal human astrocytes. J. Biochem. 150 (2011), 209–217.
81. [81] Vaka, S.R., Murthy, S.N., Repka, M.A., Nagy, T., Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid. J. Pharm. Sci. 100 (2011), 3139–3145.
82. [82] Chen, S.D., Ji, B.B., Yan, Y.X., He, X., Han, K.Y., Dai, Q.X., Zhang, M.X., Mo, Y.C., Wang, J.L., Carnosic acid attenuates neuropathic pain in rat through the activation of spinal sirtuin1 and down-regulation of p66shc expression. Neurochem. Int. 93 (2016), 95–102.
83. [83] Takahashi, T., Tabuchi, T., Tamaki, Y., Kosaka, K., Takikawa, Y., Satoh, T., Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism. Biochem. Biophys. Res. Commun. 382 (2009), 549–554.
84. [84] Gaya, M., Repetto, V., Toneatto, J., Anesini, C., Piwien-Pilipuk, G., Moreno, S., Antiadipogenic effect of carnosic acid, a natural compound present in Rosmarinus officinalis, is exerted through the C/EBPs and PPARγ pathways at the onset of the differentiation program. Biochim. Biophys. Acta 1830 (2013), 3796–3806.
85. [85] Park, M.Y., Sung, M.K., Carnosic acid inhibits lipid accumulation in 3T3-L1 adipocytes through attenuation of fatty acid desaturation. J. Cancer Prev. 20 (2015), 41–49.
86. [86] Wang, T., Takikawa, Y., Tabuchi, T., Satoh, T., Kosaka, K., Suzuki, K., Carnosic acid (CA) prevents lipid accumulation in hepatocytes through the EGFR/MAPK pathway. J. Gastroenterol. 47 (2012), 805–813.
87. [87] Dickmann, L.J., VandenBrink, B.M., Lin, Y.S., In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties. Drug Metab. Dispos. 40 (2012), 1263–1267.
88. [88] Ninomiya, K., Matsuda, H., Shimoda, H., Nishida, N., Kasajima, N., Yoshino, T., Morikawa, T., Yoshikawa, M., Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorg. Med. Chem. Lett. 14 (2004), 1943–1946.
89. [89] Ibarra, A., Cases, J., Roller, M., Chiralt-Boix, A., Coussaert, A., Ripoll, C., Carnosic acid-rich rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and improves cholesterol levels and glycaemia in mice on a high-fat diet. Br. J. Nutr. 106 (2011), 1182–1189.
90. [90] Romo Vaquero, M., Yáñez-Gascón, M.J., García Villalba, R., Larrosa, M., Fromentin, E., Ibarra, A., Roller, M., Tomás-Barberán, F., Espín de Gea, J.C., García-Conesa, M.T., Inhibition of gastric lipase as a mechanism for body weight and plasma lipids reduction in Zucker rats fed a rosemary extract rich in carnosic acid. PLoS One, 7, 2012, e39773.
91. [91] Romo-Vaquero, M., Larrosa, M., Yáñez-Gascón, M.J., Issaly, N., Flanagan, J., Roller, M., Tomás-Barberán, F.A., Espín, J.C., Garcia-Conesa, M.T., A rosemary extract enriched in carnosic acid improves circulating adipocytokines and modulates key metabolic sensors in lean Zucker rats: critical and contrasting differences in the obese genotype. Mol. Nutr. Food Res. 58 (2014), 942–953.
92. [92] Park, M.Y., Sung, M.K., Carnosic acid attenuates obesity-induced glucose intolerance and hepatic fat accumulation by modulating genes of lipid metabolism in C57BL/6J-ob/ob mice. J. Sci. Food Agric. 95 (2015), 828–835.
93. [93] Zhao, Y., Sedighi, R., Wang, P., Chen, H., Zhu, Y., Sang, S., Carnosic acid as a major bioactive component in rosemary extract ameliorates high-fat-diet-induced obesity and metabolic syndrome in mice. J. Agric. Food Chem. 63 (2015), 4843–4852.
94. [94] Romo-Vaquero, M., Selma, M.V., Larrosa, M., Obiol, M., García-Villalba, R., González-Barrio, R., Issaly, N., Flanagan, J., Roller, M., Tomás-Barberán, F.A., García-Conesa, M.T., A rosemary extract rich in carnosic acid selectively modulates caecum microbiota and inhibits β-glucosidase activity, altering fiber and short chain fatty acids fecal excretion in lean and obese female rats. PLoS One, 9, 2014, e94687.
95. [95] Yan, H., He, W., Li, X., Nie, C., Wang, L., Li, X., Wu, L., Tu, P., Determination of carnosic acid in rat stomach and intestine by high performance liquid chromatography method. Zhongguo Zhong Yao Za Zhi. 34 (2009), 766–769.
96. [96] Pertino, M.W., Theoduloz, C., Rodríguez, J.A., Yáñez, T., Lazo, V., Schmeda-Hirschmann, G., Gastroprotective effect of carnosic acid gamma-lactone derivatives. J. Nat. Prod. 73 (2010), 639–643.
97. [97] Theoduloz, C., Pertino, M.W., Rodríguez, J.A., Schmeda-Hirschmann, G., Gastroprotective effect and cytotoxicity of carnosic acid derivatives. Planta Med. 77 (2011), 882–887.
98. [98] Fisher, G.J., Datta, S.C., Talwar, H.S., Wang, Z.Q., Varani, J., Kang, S., Voorhees, J.J., Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 379 (1996), 335–339.
99. [99] Peus, D., Vasa, R.A., Meves, A., Beyerle, A., Pittelkow, M.R., UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem. Photobiol. 72 (2000), 135–140.
100. [100] Offord, E.A., Gautier, J.C., Avanti, O., Scaletta, C., Runge, F., Krämer, K., Applegate, L.A., Photoprotective potential of lycopene, beta-carotene, vitamin E, vitamin C and carnosic acid in UVA-irradiated human skin fibroblasts. Free Radic. Biol. Med. 32 (2002), 1293–1303.
101. [101] Park, M., Han, J., Lee, C.S., Soo, B.H., Lim, K.M., Ha, H., Carnosic acid, a phenolic diterpene from rosemary, prevents UV-induced expression of matrix metalloproteinases in human skin fibroblasts and keratinocytes. Exp. Dermatol. 22 (2013), 336–341.
102. [102] Oh, J., Yu, T., Choi, S.J., Yang, Y., Baek, H.S., An, S.A., Kwon, L.K., Kim, J., Rho, H.S., Shin, S.S., Choi, W.S., Hong, S., Cho, J.Y., Syk/Src pathway-targeted inhibition of skin inflammatory responses by carnosic acid. Mediators Inflamm., 2012, 781375, 10.1155/2012/781375.
103. [103] Lee, J.J., Jin, Y.R., Lee, J.H., Yu, J.Y., Han, X.H., Oh, K.W., Hong, J.T., Kim, T.J., Yun, Y.P., Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis. Planta Med. 73 (2007), 121–127.
104. [104] Shin, H.B., Choi, M.S., Ryu, B., Lee, N.R., Kim, H.I., Choi, H.E., Chang, J., Lee, K.T., Jang, D.S., Inn, K.S., Antiviral activity of carnosic acid against respiratory syncytial virus. Virol. J., 10, 2013, 303.
105. [105] Sahu, B.D., Rentam, K.K., Putcha, U.K., Kuncha, M., Vegi, G.M., Sistla, R., Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Food Chem. Toxicol. 49 (2011), 3090–3097.
106. [106] Lipina, C., Hundal, H.S., Carnosic acid stimulates glucose uptake in skeletal muscle cells via a PME-1/PP2A/PKB signalling axis. Cell Signal. 26 (2014), 2343–2349.
107. [107] Tsai, C.W., Liu, K.L., Lin, Y.R., Kuo, W.C., The mechanisms of carnosic acid attenuates tumor necrosis factor-α-mediated inflammation and insulin resistance in 3T3-L1 adipocytes. Mol. Nutr. Food Res. 58 (2013), 654–664.
108. [108] Fuhrman, B., Volkova, N., Rosenblat, M., Aviram, M., Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid. Redox Signal. 2 (2002), 491–506.
109. [109] Merad, M., Soufi, W., Ghalem, S., Boukli, F., Baig, M.H., Ahmad, K., Kamal, M.A., Molecular interaction of acetylcholinesterase with carnosic acid derivatives: a neuroinformatics study. CNS Neurol. Disord. Drug Targets 13 (2014), 440–446.
110. [110] Petersen, M., Simmonds, M.S., Rosmarinic acid. Phytochemistry 62 (2003), 121–125.
111. [111] Bais, H.P., Walker, T.S., Schweizer, H.P., Root specific elicitation and antimicrobial activity of rosmarinic acid in hairy root cultures of Ocimum basilicum. Plant Physiol. Biochem. 40 (2002), 983–995.
112. [112] Osakabe, N., Takano, H., Sanbongi, C., Yasuda, A., Yanagisawa, R., Inoue, K., Yoshikawa, T., Anti-inflammatory and anti-allergic effect of rosmarinic acid (RA) inhibition of seasonal allergic rhinoconjunctivitis (SAR) and its mechanism. Biol. Factors 21 (2004), 127–131.
113. [113] Huang, S.S., Zheng, R.L., Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett. 239 (2006), 271–280.
114. [114] Sui, X., Liu, T., Ma, C., Yang, L., Zu, Y., Zhang, L., Wang, H., Microwave irradiation to pretreat rosemary (Rosmarinus officinalis L.) for maintaining antioxidant content during storage and to extract essential oil simultaneously. Food Chem. 131 (2012), 1399–1405.
115. [115] Kim, D.S., Kim, H.R., Woo, E.R., Hong, S.T., Chae, H.J., Chae, S.W., Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase. Biochem. Pharm. 70 (2005), 1066–1078.
116. [116] Li, G.S., Jiang, W.L., Tian, J.W., Qu, G.W., Zhu, H.B., Fu, F.H., In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis. Phytomedicine 17 (2010), 282–288.